do not release - profile to be deleted
Latest Information Update: 06 Jun 2024
At a glance
- Originator LG Chem
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 16 Apr 2024 LR 19155 is available for licensing as of 16 Apr 2024. https://innovation.lgchem.com/ResearchDevelopment/Partnership.do
- 16 Apr 2024 Preclinical trials in Cancer in South Korea (unspecified route) (LG Chem Pipeline, April 2024)